Medindia

X

Medecins Sans Frontieres Calls For Cautious Approach On EU-India Free Trade Agreement

by Shirley Johanna on  October 8, 2015 at 6:38 PM General Health News   - G J E 4
Medecins Sans Frontieres (MSF/Doctors Without Borders) called for a cautious approach from Indian negotiators on the reinstatement of talks for the EU-India free trade agreement which was discussed during German Chancellor Angela Merkel's visit.
Medecins Sans Frontieres Calls For Cautious Approach On EU-India Free Trade Agreement
Medecins Sans Frontieres Calls For Cautious Approach On EU-India Free Trade Agreement
Advertisement

The European Union is only a few formal steps away from adopting and enacting new European Trademark rules, which will allow EU customs officials to seize goods in transit suspected of counterfeit (wilful) trademark infringement, unless a holder of legitimate goods (such as low-cost generic medicines) - can prove that there is no infringement of the relevant trademark in the country of destination, the MSF said.

Advertisement
MSF and other organizations have repeatedly called for the removal of any border measures that allow trademark enforcement on goods in transit, given previous seizures of generic medicines within the European Union that were intended to provide life-saving treatment in developing countries, it said.

Any seizure of legitimate low-cost generic medicines could introduce a substantial new barrier to low-cost generic competition that undermine producers and purchasers of low-cost generic medicines, and more broadly have a negative impact on treatment programs in developing countries.

"By introducing a new right to stop and seize goods in transit through the European Union on just the suspicion of counterfeit (wilful) trademark infringement, the EU is about to take another unacceptable step beyond internationally-agreed trade rules to the detriment of affordable access to medicines in low- and middle-income countries," the MSF said.

The EU-India Free Trade Agreement (FTA) has been in negotiations since 2007. From the outset, the European Commission has pushed to include provisions that would undermine India's ability to produce affordable medicines on which millions of people in developing countries rely.

Source: IANS
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All